Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study

Summary Background Adherence is an overall marker of treatment success, and it depends on multiple factors including efficacy and safety. Despite the wide use of tumour necrosis factor (TNF)‐α blockers in the treatment of plaque‐type psoriasis, few data regarding treatment adherence in routine clini...

Full description

Saved in:

Bibliographic Details
Published in:	British journal of dermatology (1951) Vol. 169; no. 3; pp. 666 - 672
Main Authors:	Esposito, M., Gisondi, P., Cassano, N., Ferrucci, G., Del Giglio, M., Loconsole, F., Giunta, A., Vena, G.A., Chimenti, S., Girolomoni, G.
Format:	Journal Article
Language:	English
Published:	Oxford Blackwell Publishing Ltd 01.09.2013 Wiley-Blackwell
Subjects:	Adalimumab Adolescent Adult Aged Aged, 80 and over Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized - therapeutic use Biological and medical sciences Dermatologic Agents - therapeutic use Dermatology Etanercept Female Humans Immunoglobulin G - therapeutic use Immunologic Factors - therapeutic use Infliximab Kaplan-Meier Estimate Male Medical sciences Medication Adherence Middle Aged Psoriasis - drug therapy Psoriasis - mortality Psoriasis. Parapsoriasis. Lichen Receptors, Tumor Necrosis Factor - therapeutic use Treatment Outcome Tumor Necrosis Factor-alpha - antagonists & inhibitors Young Adult Antineoplastic agent Skin disease Observational study Prognosis Treatment Psoriasis Dermatology Multicenter study Rate Survival Necrosis
ISSN:	0007-0963, 1365-2133, 1365-2133
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!